A metalloproteinase-9 polymorphism which affects its expression is associated with increased risk for oral squamous cell carcinoma

European Journal of Surgical Oncology

Volumn 34, Issue 4, 2008, Pages 450-455

  Vairaktaris, E ^a   Vassiliou, S ^a   Nkenke, E ^b   Serefoglou, Z ^a   Derka, S ^a   Tsigris, C ^a   Vylliotis, A ^a   Yapijakis, C ^a   Neukam, F W ^b   Patsouris, E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Angiogenesis; Metalloproteinase 9; Oncogenesis; Oral cancer; Polymorphism; Tumor progression

Indexed keywords

ANGIOSTATIN; GELATINASE B; PLASMINOGEN;

ADULT; AGED; ALCOHOL ABUSE; ALLELE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER RISK; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; THROMBOPHILIA;

ADULT; AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK FACTORS; SMOKING;

EID: 40849136461     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2007.03.024     Document Type: Article

References (37)

1. McDowell J.D. An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin of North Am 39 (2006) 277-294
2. Tsai M.H., Chen W.C., Chen H.Y., and Tsai F.J. Urokinase gene 3′-UTR T/C polymorphism is associated with oral cancer. J Clin Lab Anal 18 (2004) 276-279
3. Vairaktaris E., Yapijakis C., Derka S., et al. Association of platelet Ia polymorphism with minor increase of risk for oral cancer. Eur J Surg Oncol 32 (2006) 455-457
4. Vairaktaris E., Yapijakis C., Serefoglou Z., et al. Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 42 (2006) 888-892
5. Vairaktaris E., Yapijakis C., Serefoglou Z., et al. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol 33 (2007) 504-507
6. Alvarez B., Ruiz C., Chacon P., et al. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. J Vasc Surg 40 (2004) 469-475
7. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., and Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 72 (2006) 1605-1621
8. Ruokolainen H., Pääkkö P., and Turpeenniemi-Hujanen T. Expresssion of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis. Clin Cancer Res 10 (2004) 3110-3116
9. John A., and Tuszynski G. The role of matrix metalloproteinases in tumour angiogenesis and tumour metastasis. Pathol Oncol Res 7 (2001) 14-23
10. Nagase H., and Woessner J.F. Matrix metalloproteinases. J Biol Chem 274 (1999) 21491-21494
11. Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochimica et Biophysica Acta 1477 (2000) 267-283
12. Stetler-Stevenson W.G. The role of matrix metalloproteinases in tumour invasion, metastasis, and angiogenesis. Surg Oncol Clin N Am 10 (2001) 383-392
13. Schnaper H.W., Grant D.S., Stetler-Stevenson W.G., et al. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. Cell Physiol 156 (1993) 235-246
14. Iurlaro M., Loverro G., Vacca A., et al. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma. Eur J Clin Invest 29 (1999) 793-801
15. Koivunen E., Arap W., Valtanen H., et al. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 17 (1999) 768-774
16. Eccles S.A., Box G.M., Court W.J., et al. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res 56 (1996) 2815-2822
17. Patterson B.C., and Sang Q.A. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272 (1997) 28823-28825
18. Duffy M.J., Maguire T.M., Hill A., et al. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2 (2000) 252-257
19. Ohashi K., Nemoto T., Nakamura K., and Nemori R. Increased expression of matrix metalloproteinase 7 and 9 membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Am Cancer Society 88 (2000) 2201-2209
20. Kallakury B.V., Karikehalli S., Haholu A., Sheehan C.E., Azumi N., and Ross J.S. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res 7 (2001) 3113-3119
21. Franchi A., Santucci M., Masini E., Sardi I., Paglierani M., and Gallo O. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Am Cancer Society 96 (2002) 1902-1910
22. Tsai C.H., Hsieh Y.S., Yang S.F., Chou M.Y., and Chang Y.C. Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations. Oral Surg Oral Med Oral Pathol 95 (2003) 710-716
23. Shellman Y.G., Makela M., and Norris D.A. Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Melanoma Res 16 (2006) 207-211
24. Kim T.D., Song K.S., Li G., et al. Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. MBC Cancer 6 (2006) 211 [Epub ahead of print]
25. Juarez J., Clayman G., Nakajima M., et al. Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int J Cancer 55 (1993) 10-18
26. 6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer 92 (2001) 641-650
27. Zhang B., Henney A., Eriksson P., Hamsten A., Watkins H., and Ye S. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1. Hum Genet 105 (2004) 418-423
28. Zhang B., Ye S., Herrmann S.M., et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99 (1999) 1788-1794
29. Grieu F., Li W.Q., and Iacopetta B. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat 88 (2004) 197-204
30. Wang Y., Fang S., Lizhen W., et al. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma. Lung Cancer 49 (2005) 155-161
31. Pollänen P.J., Lehtimäki T., Mikkelsson J., et al. Matrix metalloproteinase 3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques. Atherosclerosis 180 (2005) 73-78
32. Matsumura S., Oue N., Nakayama H., et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol 131 (2005) 19-25
33. Li Y., Jin X., Kang S., et al. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol 101 (2006) 92-96
34. Elander N., Soderkvist P., and Fransen K. Matrix metalloproteinase (MMP)-1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 26 (2006) 791-795
35. Ikebe T., Nakayama H., Shinohara M., and Shirasuna K. NF-kB involvement in tumor-stroma interaction of squamous cell carcinoma. Oral Oncol 40 (2004) 1048-1056
36. Kato K., Hara A., Kuno T., et al. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity. J Cancer Res Clin Oncol 131 (2005) 340-346
37. Schnaper H.W., Barnathan E.S., Mazar A., et al. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways. Cell Physiol 165 (1995) 107-118